Characterization of features and outcomes of young patients (<45 years) presenting with ST-segment elevation

Ahmad Samir1, Mohammed Almahjori2, Basem Zarif3

  • 1Faculty of Medicine, Cairo University, Cairo, Egypt. ahmadsamir11@cu.edu.eg.

Insights

Younger patients with ST-elevation myocardial infarction (STEMI) have distinct risk factors like smoking and family history but fewer adverse events. Despite better outcomes, 1-year mortality remains similar to older STEMI patients.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary artery disease (CAD) is a leading global cause of death.
  • ST-segment elevation myocardial infarction (STEMI) significantly impacts younger individuals psychologically and economically.
  • Limited data exists on young STEMI patients in Egypt.

Purpose of the Study:

  • To characterize young STEMI patients (≤45 years) in Egypt.
  • To compare their features and outcomes against older STEMI patients (>45 years).
  • To evaluate 1-year outcomes for both young and older STEMI patient groups.

Main Methods:

  • Recruited 492 STEMI patients from National Heart Institute and Cairo University Hospitals.
  • Categorized patients into young (≤45 years) and older (>45 years) groups.
  • Followed patients for at least 12 months post-event, assessing clinical characteristics and outcomes.

Main Results:

  • Young STEMI patients constituted 20% of all cases, predominantly male (87%).
  • Younger patients showed higher rates of smoking (72.4%) and family history (13.3%), with lower rates of diabetes, hypertension, and dyslipidemia.
  • Younger patients experienced fewer major adverse cardiovascular events (MACE) and heart failure hospitalizations (10.2% vs. 23.9%), but 1-year mortality was similar (3.1% vs. 4.1%).

Conclusions:

  • Young STEMI patients exhibit unique profiles, including increased smoking and family history, and reduced conventional risk factors.
  • While younger STEMI patients have better short-term outcomes regarding MACE, long-term mortality is comparable to older patients.
  • These findings highlight the need for targeted prevention and management strategies for young STEMI populations.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
25
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
15
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
36
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
14
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
18
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17